Healthy Volunteer (HV)
Showing 1 - 25 of >10,000
Patients With Different Neurological Conditions
Recruiting
- Nervous System Disease
- Healthy Volunteer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Unit Healthy Volunteer Protocols
Recruiting
- Zika
- Influenza
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Measuring Hydrogen Peroxide in Exhaled Breath Condensate in HV
Completed
- Proof Of Concept Study
- Measurement of inhaled measuring hydrogen peroxide in exhaled breath
-
London, United KingdomImperial Clinical Respiratory Research Unit (ICRRU), St Mary's H
Apr 25, 2023
Postpartum Weight Retention, Pregnancy Weight Gain, Overweight and Obesity Trial (Healthy for Two-Home Visiting (H42-HV), "Usual
Not yet recruiting
- Postpartum Weight Retention
- +3 more
- Healthy for Two-Home Visiting (H42-HV)
- "Usual Home Visiting Plus" (mHIP-HV)
- (no location specified)
Nov 9, 2022
Healthy Volunteer Trial in Hong Kong (Hybrid volunteer training programme)
Recruiting
- Healthy Volunteer
- Hybrid volunteer training programme
-
Hong Kong, Hong Kong
- +1 more
Jan 6, 2023
Development of Novel MR Techniques Using Volunteer Participants
Recruiting
- Healthy
- magnetic resonance
-
London, United KingdomUniversity College London
Jul 4, 2023
Cystic Fibrosis Trial in Christchurch (ABCI, Placebo)
Recruiting
- Cystic Fibrosis
- ABCI
- Placebo
-
Christchurch, New ZealandNew Zealand Clinical Research
Apr 4, 2023
Healthy Trial in Lund (Lumentin® 44 Powder for oral foam)
Completed
- Healthy
- Lumentin® 44 Powder for oral foam
-
Lund, Skåne, SwedenPeritusClinic
Mar 10, 2023
Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Brisbane (ADX-038, Placebo)
Not yet recruiting
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- ADX-038
- Placebo
-
Brisbane, Queensland, AustraliaNucleus Network Brisbane
May 17, 2023
Healthy Trial in Oslo (ODI-Tech medical device)
Recruiting
- Healthy
- ODI-Tech medical device
-
Oslo, NorwayODI Medical
Nov 2, 2022
Healthy Volunteer Trial in Leeds (Aspirin, rivaroxaban low dose, rivaroxaban high dose)
Recruiting
- Healthy Volunteer
- Aspirin
- +2 more
-
Leeds, West Yorkshire, United KingdomLabCorp CRU
Jan 24, 2023
Intrahepatic Cholangiocarcinoma Trial in Shanghai (HMPL-453, Rabeprazole)
Active, not recruiting
- Intrahepatic Cholangiocarcinoma
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Jun 24, 2023
Cachexia Trial in Ruddington (Part 1 Group 1 (ACM-001.1and Pindolol and Placebo), Part 1 Group 2 (Pindolol), Part 2 Group D
Completed
- Cachexia
- Part 1 Group 1 (ACM-001.1and Pindolol and Placebo)
- +5 more
-
Ruddington, United KingdomQuotient Sciences Ltd
Aug 31, 2023
Parkinson Disease Trial in Turku (HER-096, Placebo)
Recruiting
- Parkinson Disease
- HER-096
- Placebo
-
Turku, FinlandClinical Research Services Turku - CRST Oy
Jun 13, 2023
Healthy Volunteer Trial in Prahran (Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI),
Completed
- Healthy Volunteer
- Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI)
- Vardenafil Oral Tablet
-
Prahran, Victoria, AustraliaNucleus Network, Burnet Institute
Nov 2, 2022
Amyotrophic Lateral Sclerosis (ALS) Trial in Stanford (18F-OP-801)
Not yet recruiting
- Amyotrophic Lateral Sclerosis (ALS)
-
Stanford, CaliforniaStanford University
May 25, 2022
Stress Trial in Leuven (Stress paradigm, Sham paradigm)
Recruiting
- Stress
- Stress paradigm
- Sham paradigm
-
Leuven, Vlaams-Brabant, BelgiumTARGID
Jun 16, 2022
Visual Motor Coordination
Recruiting
- Healthy Volunteer
- Neurodegenerative Diseases
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Asthma, COPD (COPD) Trial in Baltimore (CHF5993, CHF5259, Moxifloxacin 400mg)
Recruiting
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- CHF5993
- +3 more
-
Baltimore, MarylandPAREXEL Baltimore Early Phase Clinical Unit
Apr 13, 2023
Healthy Trial in Indianapolis (Inulin)
Recruiting
- Healthy
- Inulin
-
Indianapolis, IndianaIndiana University
Feb 15, 2022